Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 18.05.2026 1 BMC Cancer 1 Cancer Res 3 Childs Nerv Syst 3 Clin Neuropathol 1 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 12 J Neurooncol 3 J Neurosurg 9 Neuro Oncol 2 Neuroradiology 1 Neurosurgery 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. VERA K, Esken G, Hwang JW, Elbaz C, et al
   A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFR(VIII)-mutated glioblastoma cells via macrophages.
   BMC Cancer. 2026 May 8. doi: 10.1186/s12885-026-16080.
   PubMed         Abstract available
   
   

   
   Cancer Res

2. FRIEDEL RH, Zou H
   Interplay of glioblastoma cells with microglia shape invasive phenotypes during long-distance invasion.
   Cancer Res. 2026 May 12. doi: 10.1158/0008-5472.CAN-26-2075.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

3. ZENG Y, Chen K, Shi T, Chen Z, et al
   Co-occurrence of pediatric-type diffuse high-grade gliomas with arteriovenous malformations: case report and narrative literature review.
   Childs Nerv Syst. 2026;42:217.
   PubMed         Abstract available
   
   
4. DVIR R, Peled Y, Levin D, Elhasid R, et al
   Programmable shunt valves with a "virtual off" for intrathecal chemotherapy delivery in children with high-grade CNS tumors and hydrocephalus.
   Childs Nerv Syst. 2026;42:213.
   PubMed         Abstract available
   
   
5. DA COSTA MDS, Novo PC, de Almeida Garcia TNA, de Camargo GAG, et al
   PITCH (pediatric infratentorial tumors - hydrocephalus-related complications) registry study design: observational, prospective, multicenter study evaluating the number of surgeries associated with the treatment of hydrocephalus secondary to infratent
   Childs Nerv Syst. 2026;42:208.
   PubMed         Abstract available
   
   

   
   Clin Neuropathol

6. AL-HUSSAINI M, Al Sharie S, Azzam S, Erashdi M, et al
   Bifocal cerebellar liponeurocytoma with atypical features: A case report and a literature review.
   Clin Neuropathol. 2026;45:56-65.
   PubMed         Abstract available
   
   
7. O'DONOGHUE C, Wilkins B, Beausang A, Cryan J, et al
   Retrospective neuropathologic analysis of adult spinal tumors in a single neuroscience center 2018 - 2023.
   Clin Neuropathol. 2026;45:42-48.
   PubMed         Abstract available
   
   
8. SHINTAKU M, Hashiba T, Nonaka M, Asai A, et al
   The "Azzopardi phenomenon" in high-grade astrocytoma with a PNET-like component.
   Clin Neuropathol. 2026;45:49-55.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

9. CONKLIN HM, Khan RB, Ashford JM, Owens C, et al
   Memantine for Prevention of Cognitive Late Effects in Children and Adolescents Receiving Radiotherapy for Brain Tumors: A Randomized, Controlled, Pilot Trial.
   Int J Radiat Oncol Biol Phys. 2026 May 8:S0360-3016(26)00690.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

10. HANSFORD JR, Manoharan N, Khan S, Chon R, et al
    Balancing Risk, Benefit, and Reality: Navigating Early Phase Studies in Pediatric Diffuse Midline Glioma.
    J Clin Oncol. 2026 May 12:JCO2600461. doi: 10.1200/JCO-26-00461.
    PubMed        
    
    
11. BALLMAN KV
    Lessons From GBM AGILE's Regorafenib Experience in Newly Diagnosed and Recurrent Glioblastoma.
    J Clin Oncol. 2026 May 12:JCO2600444. doi: 10.1200/JCO-26-00444.
    PubMed        
    
    

    
    J Neurooncol

12. LI M, Zhu J, Huang R, Yao X, et al
    Virus-like particle vaccine targeting meningeal lymphatic vessels via intradural delivery activates anti-glioma immunity.
    J Neurooncol. 2026;177:138.
    PubMed        
    
    
13. KLAUS FL, Maragkou T, Delbridge C, Eberhardt CG, et al
    Subtype-specific prognostic impact of TNIK in medulloblastoma.
    J Neurooncol. 2026;177:140.
    PubMed         Abstract available
    
    
14. SARFRAZ Z, Ranjan T, Mustafayev FNA, Luzarraga J, et al
    Treatment patterns and survival outcomes in neuroendocrine neoplasms presenting with brain metastases.
    J Neurooncol. 2026;177:141.
    PubMed        
    
    
15. GOEL K, Qian Y, Pollom E
    Cost-effectiveness analysis of upfront HA-WBRT vs. SRS for treatment of brain metastases due to SCLC.
    J Neurooncol. 2026;177:139.
    PubMed         Abstract available
    
    
16. CHUCK C, Teshome A, Lin A, Sayeed S, et al
    Correction to: Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).
    J Neurooncol. 2026;177:137.
    PubMed        
    
    
17. HEBDA A, Wawrzyniak P, Heinze S, Mazgaj P, et al
    Diagnostic accuracy of 1H-MRS in detecting the oncometabolite 2-hydroxyglutarate (2HG) in adult-type diffuse gliomas.
    J Neurooncol. 2026;177:149.
    PubMed         Abstract available
    
    
18. MUSHTAQ N, Bashir F, Zahid S, Shafique MA, et al
    Pediatric low-grade gliomas; a 12-year retrospective review from a tertiary care hospital in LMIC.
    J Neurooncol. 2026;177:148.
    PubMed         Abstract available
    
    
19. HERSH DS, Asher AL, Bydon M, Delawan M, et al
    Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.
    J Neurooncol. 2026;177:147.
    PubMed         Abstract available
    
    
20. ALBANO L, Losa M, Vitale GG, Reyes JS, et al
    Stereotactic radiosurgery for pediatric craniopharyngiomas: a multicenter retrospective study.
    J Neurooncol. 2026;177:146.
    PubMed         Abstract available
    
    
21. LAPTEVA K, Gavrjushin A, Veselkov A
    Intraoperative tract mapping through the biopsy cannula during stereotactic biopsy of brainstem lesions: a prospective feasibility study.
    J Neurooncol. 2026;177:145.
    PubMed         Abstract available
    
    
22. MOHL S, Tenhoeve SA, King S, Zhao Y, et al
    The impact of distance in treating glioblastoma: a retrospective single-center study.
    J Neurooncol. 2026;177:144.
    PubMed         Abstract available
    
    
23. SAMPATH SG, Tang AJ, Chen AX, Viswanathan A, et al
    cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes.
    J Neurooncol. 2026;177:142.
    PubMed         Abstract available
    
    

    
    J Neurosurg

24. NG S, Duffau H
    Intractable epilepsy before and/or after awake functional mapping-based surgery for IDH-mutant grade 2 glioma: a consecutive series of 105 patients.
    J Neurosurg. 2026 May 8:1-11. doi: 10.3171/2025.12.JNS251916.
    PubMed         Abstract available
    
    
25. YOUNG JS, Al-Adli NN, Quintana D, Menna G, et al
    Maximum safe resection of insular gliomas: update on surgical outcomes from 500 cases.
    J Neurosurg. 2026 May 8:1-17. doi: 10.3171/2025.12.JNS251889.
    PubMed         Abstract available
    
    
26. SHEE LY, Liu X, Zhai Z, Xu J, et al
    Surgical implications of BRAF V600E-positive Rathke's cleft cysts: prediction of early recurrence based on reclassification to papillary craniopharyngioma.
    J Neurosurg. 2026 May 8:1-12. doi: 10.3171/2025.12.JNS251886.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

27. HAU P
    ClpP Activation in High-Risk Medulloblastoma: ONC206 as a Potent Inducer of the Integrated Stress Response and Mitochondrial Damage for a Broader Therapeutic Window.
    Neuro Oncol. 2026 May 9:noag105. doi: 10.1093.
    PubMed        
    
    
28. KARSCHNIA P, Teske N, Le Rhun E, Wirsching HG, et al
    Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial.
    Neuro Oncol. 2026 May 10:noag103. doi: 10.1093.
    PubMed         Abstract available
    
    
29. GROBMAN B, Lamba N, Purohit S, Catalano PJ, et al
    Association between radiographic response and subsequent recurrence in brain metastases treated with radiation: implications for response assessment criteria.
    Neuro Oncol. 2026 May 10:noag106. doi: 10.1093.
    PubMed         Abstract available
    
    
30. 
    Corrigendum to: G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target alpha-thalassemia/mental retardation X-linked-deficient malignant glioma.
    Neuro Oncol. 2026 May 9:noag089. doi: 10.1093.
    PubMed        
    
    
31. 
    Corrigendum to: Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma.
    Neuro Oncol. 2026 May 9:noag092. doi: 10.1093.
    PubMed        
    
    
32. SAMMONS SL, Shanley R, Anders CK, Lin NU, et al
    Intracranial Progression-Free Survival Correlates with Overall Survival and Varies by Tumor Subtype in Patients with Breast Cancer and Brain Metastases.
    Neuro Oncol. 2026 May 12:noag102. doi: 10.1093.
    PubMed         Abstract available
    
    
33. VAN DEN BENT MJ
    Gods do play dice: The activity of regorafenib in glioblastoma not confirmed.
    Neuro Oncol. 2026 May 12:noag109. doi: 10.1093.
    PubMed        
    
    
34. 
    Corrigendum to: Multiomic profiling of glioblastoma metabolic lesions reveals complex intratumoral genomic evolution and dipeptidase-1-driven vascular proliferation.
    Neuro Oncol. 2026 May 11:noag091. doi: 10.1093.
    PubMed        
    
    
35. TAMRAZI B, Markowitz A, Margol AS, Nelson MD, et al
    Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo 1H-MR Spectroscopy.
    Neuro Oncol. 2026 May 14:noag101. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

36. ZHENG T, Yang L, Zhang D, Du J, et al
    Integrating ConvNeXt tiny and radiomics in a nomogram to differentiate true progression from pseudoprogression in glioma.
    Neuroradiology. 2026 May 9. doi: 10.1007/s00234-026-04024.
    PubMed         Abstract available
    
    
37. YUZKAN S, Yesiloglu EO, Konakci IS, Ergin HE, et al
    Meningioma versus dural metastasis: integration of T2*-DSC perfusion-derived percentage signal recovery with conventional and contemporary MRI features and clinical variables.
    Neuroradiology. 2026 May 13. doi: 10.1007/s00234-026-04030.
    PubMed         Abstract available
    
    

    
    Neurosurgery

38. KHAIRUNNISA NI, Yamasaki F, Yonezawa U, Taguchi A, et al
    Cortical Diffusion-Enhancement Mismatch Sign: A Specific Imaging Biomarker for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma.
    Neurosurgery. 2026 May 14. doi: 10.1227/neu.0000000000004089.
    PubMed         Abstract available
    
    

    
    PLoS One

39. 
    Retraction: Mitochondrial dysfunction and cell death induced by Toona sinensis leaf extracts through MEK/ERK signaling in glioblastoma cells.
    PLoS One. 2026;21:e0349173.
    PubMed        
    
    
40. SARKAR P, Ahuja S, Lazar IM
    Scaffold-free 3D-cell co-culture model system for the study of metastatic cancer in the brain TME.
    PLoS One. 2026;21:e0349061.
    PubMed         Abstract available
    
    
41. BRIGGS RG, Levy D, Chung RS, Cote DJ, et al
    Minimally-invasive resection of deep-seated subcortical and intraventricular lesions using an integrated camera-port system: A retrospective case series.
    PLoS One. 2026;21:e0348673.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum